RS60301B1 - Kombinacija protiv regurgitacije za održavanje motiliteta creva - Google Patents

Kombinacija protiv regurgitacije za održavanje motiliteta creva

Info

Publication number
RS60301B1
RS60301B1 RS20200569A RSP20200569A RS60301B1 RS 60301 B1 RS60301 B1 RS 60301B1 RS 20200569 A RS20200569 A RS 20200569A RS P20200569 A RSP20200569 A RS P20200569A RS 60301 B1 RS60301 B1 RS 60301B1
Authority
RS
Serbia
Prior art keywords
pyridine
hydroxy
treatment
propoxy
compound
Prior art date
Application number
RS20200569A
Other languages
English (en)
Serbian (sr)
Inventor
Jonathan Albert Margossian
Nicolas Pradeau
Original Assignee
United Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49237261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS60301(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by United Pharmaceuticals Sa filed Critical United Pharmaceuticals Sa
Publication of RS60301B1 publication Critical patent/RS60301B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/238—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seeds, e.g. locust bean gum or guar gum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/231—Pectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Pediatric Medicine (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
RS20200569A 2013-05-07 2014-05-07 Kombinacija protiv regurgitacije za održavanje motiliteta creva RS60301B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1354200A FR3005392B1 (fr) 2013-05-07 2013-05-07 Composition anti-regurgitation preservant le transit intestinal
EP18185253.4A EP3421092B1 (fr) 2013-05-07 2014-05-07 Composition anti-regurgitation preservant le transit intestinal

Publications (1)

Publication Number Publication Date
RS60301B1 true RS60301B1 (sr) 2020-07-31

Family

ID=49237261

Family Applications (2)

Application Number Title Priority Date Filing Date
RS20200569A RS60301B1 (sr) 2013-05-07 2014-05-07 Kombinacija protiv regurgitacije za održavanje motiliteta creva
RS20181139A RS57834B1 (sr) 2013-05-07 2014-05-07 Kombinacija protiv regurgitacije za održavanje motiliteta creva

Family Applications After (1)

Application Number Title Priority Date Filing Date
RS20181139A RS57834B1 (sr) 2013-05-07 2014-05-07 Kombinacija protiv regurgitacije za održavanje motiliteta creva

Country Status (26)

Country Link
US (2) US9554587B2 (enExample)
EP (2) EP2999357B1 (enExample)
JP (1) JP2016522823A (enExample)
KR (1) KR102285373B1 (enExample)
CN (1) CN105246356B (enExample)
AU (1) AU2014264640B2 (enExample)
BR (1) BR112015027976B1 (enExample)
CA (1) CA2911086C (enExample)
CL (1) CL2015003264A1 (enExample)
CY (2) CY1120718T1 (enExample)
DK (2) DK2999357T3 (enExample)
EA (1) EA033287B1 (enExample)
ES (2) ES2795668T3 (enExample)
FR (1) FR3005392B1 (enExample)
HR (2) HRP20181518T1 (enExample)
MA (1) MA38626B1 (enExample)
MX (1) MX379151B (enExample)
PE (1) PE20160117A1 (enExample)
PH (1) PH12015502543A1 (enExample)
PL (2) PL2999357T3 (enExample)
PT (2) PT2999357T (enExample)
RS (2) RS60301B1 (enExample)
SI (2) SI2999357T1 (enExample)
TN (1) TN2015000487A1 (enExample)
WO (1) WO2014180887A1 (enExample)
ZA (2) ZA201508156B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3029114B1 (fr) * 2014-12-01 2017-01-13 United Pharmaceuticals Composition nutritionnelle infantile dans le traitement de la dermatite atopique et de ses symptomes
KR101525948B1 (ko) * 2014-12-10 2015-06-05 주식회사 엔에스웰니스 캐롭 추출물을 유효성분으로 포함하는 남성 갱년기 예방 및 개선용 조성물
WO2017009202A1 (en) * 2015-07-10 2017-01-19 Dsm Ip Assets B.V. Food and/or feed compositions for preventing and treating inflammatory diseases
US20190201437A1 (en) * 2015-07-10 2019-07-04 Dsm Ip Assets B.V. Food compositions for managing body weight
US10058116B2 (en) * 2016-01-04 2018-08-28 Cari Genea Crossley Infant formula with improved nutritional value and digestive properties
CN109845877B (zh) * 2017-11-30 2022-07-12 内蒙古伊利实业集团股份有限公司 一种水解蛋白脱苦组合物及其产品、制备和应用
FR3100107B1 (fr) * 2019-08-28 2022-06-10 Melicerte Conseils Préparation pour épaissir le bol alimentaire
CN112823646A (zh) * 2019-11-20 2021-05-21 内蒙古伊利实业集团股份有限公司 组合物、食品或药品及其用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2949428A (en) * 1956-01-16 1960-08-16 Nat Pectin Products Company Process for rendering locust bean gum cold-water soluble
US3433650A (en) * 1967-01-12 1969-03-18 Gen Foods Corp Dry soup mix
DE2964977D1 (en) * 1978-12-07 1983-04-07 Unilever Nv A process for producing an ambient stable, starch-containing concentrate
DE69108846T2 (de) * 1990-10-24 1995-10-12 Sandoz Nutrition Ltd Vollwertnahrung aus hydrolysierten löslichen Faserstoffen.
FI920721L (fi) * 1991-02-26 1992-08-27 Hercules Inc Fett substitut
FR2699370B1 (fr) 1992-12-17 1995-01-13 Cedilac Sa Procédé pour la fabrication d'un lait infantile liquide prêt à l'emploi longue conservation et anti-régurgitation, et lait ainsi obtenu.
ATE199302T1 (de) 1994-06-29 2001-03-15 Aqualon Co Zusammensetzung zur viskositätskontrolle von flüssigen nährmitteln
US6099871A (en) * 1995-06-01 2000-08-08 Bristol-Myers Squibb Company Anti-regurgitation infant formula
EP1070457A1 (fr) * 1999-07-22 2001-01-24 Societe Des Produits Nestle S.A. Composition soluble à base de germe de caroube
US6365218B1 (en) * 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
FR2810324B1 (fr) 2000-06-19 2002-09-06 Rhodia Food S A S Caroube soluble
US20040258825A1 (en) * 2003-06-17 2004-12-23 Ndife Louis I. Nutritional compositions containing spray dried fiber
JP5448297B2 (ja) * 2003-10-16 2014-03-19 テクコム・グループ・リミテッド・ライアビリティ・カンパニー 低減した血中応答を有する低減可消化炭水化物食物
FR2913857A1 (fr) * 2007-03-22 2008-09-26 United Pharmaceuticals Soc Par Procede de preparation d'un lait infantile anti-regurgitation
US20090143343A1 (en) * 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
CN101877972B (zh) * 2007-11-20 2014-07-09 荷兰纽迪希亚公司 处理刺槐豆胶粉
US10602752B2 (en) * 2009-04-15 2020-03-31 N.V. Nutricia Anti-reflux infant nutrition
JP2011050278A (ja) 2009-08-31 2011-03-17 Kaneka Corp 胃から食道への逆流を防止した流動食
FR2968895B1 (fr) 2010-12-17 2013-04-12 United Pharmaceuticals Composition anti-regurgitation et/ou anti-reflux gastro-oesophagien, preparation et utilisations

Also Published As

Publication number Publication date
CN105246356B (zh) 2019-05-28
US9642391B1 (en) 2017-05-09
ES2689135T3 (es) 2018-11-08
AU2014264640B2 (en) 2018-08-09
TN2015000487A1 (fr) 2017-04-06
KR20160008226A (ko) 2016-01-21
EP2999357B1 (fr) 2018-08-01
DK3421092T3 (da) 2020-06-08
PH12015502543B1 (en) 2016-02-22
ZA201803059B (en) 2022-08-31
FR3005392B1 (fr) 2015-09-18
MA38626B1 (fr) 2017-11-30
CL2015003264A1 (es) 2016-05-06
PL3421092T3 (pl) 2020-09-21
FR3005392A1 (fr) 2014-11-14
KR102285373B1 (ko) 2021-08-03
CY1123012T1 (el) 2021-10-29
JP2016522823A (ja) 2016-08-04
ZA201508156B (en) 2022-03-30
MX2015015394A (es) 2016-07-11
EP2999357A1 (fr) 2016-03-30
HRP20181518T1 (hr) 2018-11-16
PT3421092T (pt) 2020-06-16
SI3421092T1 (sl) 2020-09-30
DK2999357T3 (en) 2018-10-15
MX379151B (es) 2025-03-10
CA2911086C (fr) 2022-11-01
US20160120207A1 (en) 2016-05-05
BR112015027976A2 (pt) 2017-09-12
CN105246356A (zh) 2016-01-13
PL2999357T3 (pl) 2018-12-31
EP3421092B1 (fr) 2020-04-22
US9554587B2 (en) 2017-01-31
CY1120718T1 (el) 2019-12-11
ES2795668T3 (es) 2020-11-24
HK1220870A1 (zh) 2017-05-19
MA38626A1 (fr) 2017-02-28
BR112015027976B1 (pt) 2020-10-27
PH12015502543A1 (en) 2016-02-22
EP3421092A1 (fr) 2019-01-02
EA201592128A1 (ru) 2016-05-31
HRP20200858T1 (hr) 2020-11-13
EA033287B1 (ru) 2019-09-30
SI2999357T1 (sl) 2018-11-30
WO2014180887A1 (fr) 2014-11-13
CA2911086A1 (fr) 2014-11-13
US20170119038A1 (en) 2017-05-04
PE20160117A1 (es) 2016-03-03
PT2999357T (pt) 2018-10-30
RS57834B1 (sr) 2018-12-31
AU2014264640A1 (en) 2015-12-24

Similar Documents

Publication Publication Date Title
EP1163224B1 (en) N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance
RS60301B1 (sr) Kombinacija protiv regurgitacije za održavanje motiliteta creva
JPH07206676A (ja) 糖尿病の治療用薬剤
CA2449922C (en) Pharmaceutical composition for therapy of interstitial cystitis
EP1957064A2 (en) Treatment of qt interval prolongation and diseases associated therewith
NO178696B (no) Akridinforbindelse og farmasöytisk preparat inneholdende denne
KR20250110947A (ko) 화합물의 약학적으로 사용 가능한 염 및 이의 제조 방법
CN107638391B (zh) 一种注射用苯磺顺阿曲库铵组合物
JPS5936885B2 (ja) 糖尿病治療剤
Lindenbaum et al. Effects of pyridoxine on mice after immobilization stress
CN103784397B (zh) 葛根素磷酸酯钠注射液及其制备方法
JP2010539160A (ja) 抗糖尿病作用を備える医薬組成物
EP0273253A2 (de) Verwendung von 6-Allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo-[5,4-d]azepin zur Freisetzung von Wachstumshormon
CN109925280B (zh) 一种硫辛酸注射液及其制备方法
CN104940193B (zh) 一种含辛伐他汀的降血脂血糖药物组合物及其应用
HU227343B1 (en) O-(3-piperidino-2-hydroxy-1-propyl)-hydroxymic acid halogenide derivative, its use and medicament containing it
CN104997780B (zh) 一种瑞舒伐他汀钙组合物及其在制备降血脂血糖药物中的应用
CN119235778A (zh) 一种黄芩苷滴眼液及其制备方法及应用
WO1991000091A1 (de) Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica
CN118440024A (zh) 磺酰脲类化合物、其制备方法及应用
CN119584967A (zh) 用甘氨酸转运抑制剂治疗肝性卟啉症的组合物和方法
HANDBOOK PEFR
CN102614172A (zh) T型钙离子通道阻滞剂在治疗糖尿病药物中的应用
JPH0541603B2 (enExample)